Identification of a novel fentanyl analogue: p-hydroxy-butyrylfentanyl.

Clicks: 370
ID: 51814
2019
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #2 of 17 articles by views in drug testing and analysis

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The use of new psychoactive substances (NPS) has become an important worldwide concern. In particular the use of highly potent fentanyl analogues forms a great health threat to users. In this publication, we detail the characterization of a new fentanyl analogue N-(4-hydroxyphenyl)-N-(1-phenethylpiperidin-4-yl)-butyramide (p-hydroxy-butyrylfentanyl) encountered in drug casework in the Netherlands. Characterization was performed using ultra-high performance liquid chromatography-quadrupole-time-of-flight mass spectrometry (UHPLC-Q-TOF-MS), gas chromatography-mass spectrometry (GC-MS), nuclear magnetic resonance (NMR) spectroscopy, Fourier transform infrared (FTIR) spectroscopy and X-ray fluorescence (XRF).
Reference Key
oldenhof2019identificationdrug Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Oldenhof, Sander;Ten Pierick, Angela;Bruinsma, Jildert;Eustace, Stephen;Hulshof, Janneke;van den Berg, Jorrit;Hoitink, Marnix;
Journal drug testing and analysis
Year 2019
DOI
10.1002/dta.2695
URL
Keywords
identification fentanyl new psychoactive substance nps

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.